FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis DOI
Hong Zhou,

Yanxia Wang,

Min Wu

et al.

The Journal of Pathology, Journal Year: 2024, Volume and Issue: 262(4), P. 427 - 440

Published: Jan. 17, 2024

Radiotherapy is one of the standard therapeutic regimens for medulloblastoma (MB). Tumor cells utilize DNA damage repair (DDR) mechanisms to survive and develop resistance during radiotherapy. It has been found that targeting DDR sensitizes tumor radiotherapy in several types cancer, but whether how pathways are involved MB response remain be determined. Single-cell RNA sequencing was carried out on 38 tissues, followed by expression enrichment assays. Fanconi anemia group D2 gene (FANCD2) evaluated samples public databases. The function FANCD2 examined using cell counting assays (CCK-8), clone formation, lactate dehydrogenase activity, mouse orthotopic models. FANCD2-related signaling pathway investigated peroxidation, a malondialdehyde assay, reduced glutathione FerroOrange assess intracellular iron ions (Fe

Language: Английский

Photonic control of image-guided ferroptosis cancer nanomedicine DOI Creative Commons
Min Jun Ko, Woojung Yoo, Sunhong Min

et al.

Coordination Chemistry Reviews, Journal Year: 2023, Volume and Issue: 500, P. 215532 - 215532

Published: Nov. 10, 2023

Language: Английский

Citations

19

Exploring the frontiers: the potential and challenges of bioactive scaffolds in osteosarcoma treatment and bone regeneration DOI Creative Commons
Huaiyuan Zhang, Yu Wang,

Huifen Qiang

et al.

Materials Today Bio, Journal Year: 2024, Volume and Issue: 29, P. 101276 - 101276

Published: Sept. 30, 2024

Language: Английский

Citations

8

Mitochondria targeted biomimetic platform for chemo/photodynamic combination therapy against osteosarcoma DOI

Fengtian Zhang,

Jiaoting Chen,

Weihong Luo

et al.

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 652, P. 123865 - 123865

Published: Jan. 28, 2024

Language: Английский

Citations

7

Graphene Oxide (GO) for the Treatment of Bone Cancer: A Systematic Review and Bibliometric Analysis DOI Creative Commons

Lemy Vanessa Barba-Rosado,

Domingo César Carrascal-Hernández, Daniel Insuasty

et al.

Nanomaterials, Journal Year: 2024, Volume and Issue: 14(2), P. 186 - 186

Published: Jan. 13, 2024

Cancer is a severe disease that, in 2022, caused more than 9.89 million deaths worldwide. One worrisome type of cancer bone cancer, such as osteosarcoma and Ewing tumors, which occur frequently infants. This study shows an active interest the use graphene oxide its derivatives therapy against cancer. We present systematic review analyzing current state art related to GO treating osteosarcoma, through evaluating existing literature. In this sense, studies focused on GO-based nanomaterials for potential applications were reviewed, has revealed that there excellent trend toward nanomaterials, based their thermal anti-cancer activities, treatment various therapeutic approaches. However, research needed develop highly efficient localized therapies. It suggested, therefore, photodynamic therapy, photothermal nanocarriers should be considered non-invasive, specific, alternatives osteosarcoma. These options promising approaches enhance effectiveness while also seeking reduce side effects minimize damage surrounding healthy tissues. The bibliometric analysis photochemical treatments reduced from January 2004 December 2022 extracted 948 documents with search strategy, mainly papers, conference demonstrating high-impact field supported by need selective central countries leading are United States, Iran, Italy, Germany, China, South Korea, Australia, strong collaborations At same time, most-cited papers published journals impact factors 6.0 (2021), 290 citations. Additionally, most topic high factor journals, according performed, field.

Language: Английский

Citations

6

FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis DOI
Hong Zhou,

Yanxia Wang,

Min Wu

et al.

The Journal of Pathology, Journal Year: 2024, Volume and Issue: 262(4), P. 427 - 440

Published: Jan. 17, 2024

Radiotherapy is one of the standard therapeutic regimens for medulloblastoma (MB). Tumor cells utilize DNA damage repair (DDR) mechanisms to survive and develop resistance during radiotherapy. It has been found that targeting DDR sensitizes tumor radiotherapy in several types cancer, but whether how pathways are involved MB response remain be determined. Single-cell RNA sequencing was carried out on 38 tissues, followed by expression enrichment assays. Fanconi anemia group D2 gene (FANCD2) evaluated samples public databases. The function FANCD2 examined using cell counting assays (CCK-8), clone formation, lactate dehydrogenase activity, mouse orthotopic models. FANCD2-related signaling pathway investigated peroxidation, a malondialdehyde assay, reduced glutathione FerroOrange assess intracellular iron ions (Fe

Language: Английский

Citations

6